Syed A. Ahmad
@SyedAAhmad5
Director University of Cincinnati Cancer Center, Chief Surgical Oncology University of Cincinnati, All things Duke Basketball. Tweets and retweets are my own.
ID:1253135480356511744
23-04-2020 01:37:36
17,5K Tweets
11,7K Followers
694 Following
Follow People
Do you omit #SentinelNodeBiopsy in Women Age ≥ 65 Years with ER+ #BreastCancer ?
Prospective, observational, single center study Catherine M Dang, MD Farin Amersi
rdcu.be/dIN1k
Syed A. Ahmad
AnnalsSurgOncology
Syed A. Ahmad The solution is MELD exception points and the expanded use of normothermic perfusion. Together they can help patients acquire better grafts and mitigate risk. This would allow us to be more aggressive with therapies like HAI as a bridge. /fin
Syed A. Ahmad Most recipients will need an aortic jump graft if they have HAI. This is morbid - it receives risk adjustment from UNOS. When combined with the livers currently used (DCD, discards, etc.) it presents a lot of combined synergistic morbidity. 2/3
Syed A. Ahmad I’ve always thought HAI has a role in bridging these patients (and ICCa patients) especially in countries with high incidence of chronic liver disease and relative graft shortage as compared to graft surplus.
#ASCO24 - NEOPRISM showed 6 weeks of pre-op Pembrolizumab in dMMR #CRC showed high pCR and 100% 3Y DFS. How much more evidence do we need to offer this to patients with bulky dMMR #coloncancer ? Kristen Ciombor COLONTOWN
Syed A. Ahmad ASCO Jordan Kharofa Shimul A. Shah Davendra Sohal IHPBA Julio Mayol Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE 🇺🇸 Flavio G Rocha, MD, FACS, FSSO Skye C. Mayo, MD, MPH Jash Datta, MD It’s hard to say something is the standard if the vast majority of patients won’t be eligible for it.
Another tool in the toolbox and for the right patient at the right time - a powerful therapy.
Congratulations Dr. Rene Adam for RCT demonstrating improved OS with #LiverTransplant for patients with metastatic #ColorectalCancer ! Although most patients had a recurrence, OS profoundly increased. 👏🏽👏🏽👏🏽 #ASCO24
ORCHESTRA 🎻 trial shows no benefit and increased morbidity to tumor debulking compared to SOC for #mCRC with multifocal visceral disease #ASCO24
OHSU Department of Surgery OHSU Knight Cancer Institute Divya Sood OncoAlert
Is thermal ablation 🔥 equivalent to
resection🔪for <3cm, well-located #CRLM
Results of the 🇳🇱 COLLISION suggests so
ASCO #ASCO24 OncoAlert
OHSU Department of Surgery OHSU Knight Cancer Institute The Dotter Institute
#ASCO24 : Dr Rene Adam TransMET showed major OS benefit, HR =0.16 of #livertransplant in liver unresectable #CRC . Recurrences mostly ex-liver and treated in transplant arm. OncoAlert Flavio G Rocha, MD, FACS, FSSO Fight Colorectal Cancer
Is RFA as good as resection for small colorectal metastases? Results of the Collision Study presented at ASCO #ASCO24
Jordan Kharofa Shimul A. Shah Flavio G Rocha, MD, FACS, FSSO Skye C. Mayo, MD, MPH Hop S. Tran Cao Julio Mayol Tom Varghese Jr. MD, MS, MBA, FACS, MAMSE 🇺🇸
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study The Lancet Oncology thelancet.com/journals/lanon…